GLOW Blend 70mg
$125.00
99%+ Purity
A three-peptide research blend — Body Protection Compound 157, TB and GHK — for parallel investigation of cytoprotective, actin-dynamics and matrix-remodelling pathways in cellular models.
Batch and certificate of analysis
Current lot P-9377026 · 70 mg · tested May 9, 2026 · Horizon Analytical. The results below are from the certificate for this exact lot, not a representative sample.
| Parameter | Result | Method | Specification |
|---|---|---|---|
| Identity | 3-peptide blend · Pass | UPLC/MS | Confirmed |
| Appearance | Blue lyophilized powder | Visual | Meets specification |
| Purity | 99.26% · Pass | UPLC/MS | Specification > 98% |
| Net content | 68.9 mg | UPLC/MS | Labeled 70 mg |
Measured content by component
| Component | Labeled | Measured | Purity |
|---|---|---|---|
| Body Protection Compound 157 | 10 mg | 9.85 mg | 99.26% |
| TB | 10 mg | 9.85 mg | 99.35% |
| GHK | 50 mg | 49.2 mg | 99.45% |
Certificates for every released lot of this product are on the COA page.
Research specifications
| Form | Lyophilised powder in a sealed glass vial |
| Labeled content | 70 mg |
| Appearance (current lot) | Blue lyophilized powder |
| Storage | Sealed vials cold, dry and protected from light; frozen for long-term storage |
| Intended use | Laboratory research only |
Composition and identifiers
| Component | Labeled | Residues | Molecular formula | Molecular weight | CAS | PubChem |
|---|---|---|---|---|---|---|
| Body Protection Compound 157 | 10mg | 15 | C62H98N16O22 | 1419.5 g/mol | 137525-51-0 | 9941957 |
| TB | 10mg | 43 | C212H350N56O78S | 4963.0 g/mol | Not listed | 45382195 |
| GHK | 50mg | 3 | C14H24N6O4 | 340.38 g/mol | 49557-75-7 | 73587 |
GHK is supplied as its copper complex (PubChem CID 71587328, C14H23CuN6O4+, 402.92 g/mol); the row above lists the tripeptide record.
Identifiers are the values PubChem lists for the named record, checked September 2026. Where PubChem lists no CAS number, none is shown.
Identity, composition and analytical documentation
Each released lot is tested by an independent laboratory (Horizon Analytical for the current lot). The certificate reports identity by mass spectrometry, purity by UPLC/MS, and net content measured against the labeled amount, for each component of the blend. A separate endotoxin report accompanies the certificate for this lot. The certificate does not include heavy-metal, sterility, residual-solvent or microbial testing. The lot number on the certificate is the lot number on the vial, so a certificate can be matched to the material in hand. Certificates for every lot released on this site remain available on the COA page.
Research overview
Findings below are from the cited laboratory and animal studies; nothing here describes effects in people.
Research Overview
The GLOW Blend is a three-peptide research formulation: Body Protection Compound 157 (10 mg), TB (10 mg) and GHK supplied as its copper complex (50 mg) in one lyophilised vial, 70 mg labeled content. Each component is measured separately on the lot's certificate, so the composition stated here is the composition that was tested. The KLOW Blend is the same three components plus KPV.
What each component is
Body Protection Compound 157 is a 15-residue synthetic peptide derived from a gastric-juice protein, studied in cell and animal models for cytoprotective signalling. TB is a 43-residue actin-binding peptide of the thymosin family, studied for its role in actin dynamics and cell migration. GHK is a copper-binding tripeptide studied for copper-dependent gene-expression changes and extracellular-matrix remodelling in fibroblast and skin-model systems.
Why the three are studied together
The components act through non-overlapping pathways in the literature — cytoprotective signalling, actin dynamics and copper-dependent matrix biology — and the blend exists so a laboratory can expose one preparation to a model system and compare the result against the single-compound preparations. Whether the three behave differently together than apart is a question for the experiment, not a property of the product. Findings in the literature are from cell culture and animal studies; nothing here describes effects in people.
Laboratory applications include fibroblast culture assays, migration and scratch-closure assays, collagen and glycosaminoglycan quantification, concentration-response characterisation of each component, and comparative analyses against the single components and the four-component KLOW Blend. The pre-mixed formulation provides consistent ratios between preparations. The GLOW Blend is supplied as lyophilised powder requiring reconstitution with bacteriostatic water. Certificate of Analysis is included for identity and purity verification.
Explore the PeptidesATX Research Library for additional peptide pharmacology guides and reference resources.
GLOW compared with KLOW
The two blends differ by one component. Rows describe composition and documentation, not effects.
| GLOW Blend 70mg | KLOW Blend 80mg | |
|---|---|---|
| Components | Body Protection Compound 157 · TB · GHK | Body Protection Compound 157 · TB · GHK · KPV |
| Labeled amounts | 10 mg · 10 mg · 50 mg | 10 mg · 10 mg · 50 mg · 10 mg |
| Fourth component | None | KPV, a melanocortin-derived tripeptide |
| Certificate of analysis | Per-component measured content on one certificate | Per-component measured content on one certificate |
Scientific references
- Sikiric P, et al. Curr Neuropharmacol. 2016;14(8):857–865. PubMed 27138887
- Goldstein AL, Hannappel E, Kleinman HK. Trends Mol Med. 2005;11(9):421–429. PubMed 16099219
- Pickart L, Margolina A. Int J Mol Sci. 2018;19(7):1987. PubMed 29986520
Related research guides
- GLOW research blend guide — component-by-component overview of the blend
- GLOW vs KLOW — how the two blends differ
- GHK research guide — the copper tripeptide in depth
- Body Protection Compound 157 vs TB — the two other components compared
Frequently asked questions
- Which lot will I receive, and how do I check it?
- The lot shown on this page (P-9377026) is the one currently shipping; when a new lot is released, this page and the COA page update together. The lot number is printed on the vial label and matches the certificate.
- What does the certificate of analysis cover?
- Identity and purity by UPLC/MS from an independent laboratory (Horizon Analytical), measured net content against the labeled amount, measured content of each component, and appearance, with a separate endotoxin report; both documents are linked above as PDFs. The certificate does not include heavy-metal, sterility, residual-solvent or microbial testing.
- How is a blend documented?
- The certificate reports each component separately: the amount measured against the amount labeled, and the purity of the blend as tested. A single purity figure without the per-component breakdown would not tell you what the vial contains.
- How should the vial be stored on receipt?
- Sealed lyophilised vials are kept cold, dry and away from light; long-term storage is frozen. The handling notes on this page and the storage guide give the laboratory practice in more detail.
- When does an order ship?
- Orders placed before the daily cutoff shown above ship the same business day from Austin, Texas, with tracking. Delivery estimates and the free-shipping threshold are shown in the order summary.